General Information of the Compound
Compound ID
CP0551021
Compound Name
US9029360, 4
    Show/Hide
Synonyms
PMID28067079-Compound-79
Pyrazolopyrimidine derivative 2
    Show/Hide
Structure
Formula
C16H16BrN5OS
Molecular Weight
406.309
Canonical SMILES
CCc1nc2CCN(CCc2s1)C(=O)c1cc2ncc(Br)cn2n1
    Show/Hide
InChI
InChI=1S/C16H16BrN5OS/c1-2-15-19-11-3-5-21(6-4-13(11)24-15)16(23)12-7-14-18-8-10(17)9-22(14)20-12/h7-9H,2-6H2,1H3
    Show/Hide
InChIKey
OEYKQCOFIDDHKA-UHFFFAOYSA-N
Physicochemical Property
logP
2.7517
Rotatable Bonds
2
Heavy Atom Count
24
Polar Areas
63.39
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71739469
ChEMBL ID
CHEMBL3672900
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00854, Metabotropic glutamate receptor 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Pyrazolopyrimidine derivative 2 )
Drug Name Pyrazolopyrimidine derivative 2
Company BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Target(s)
Metabotropic glutamate receptor 5 (mGluR5)
Modulator